MMP9 and neoplasm: In these mice, the lack of LCN2 caused a significant reduction in immune cell infiltration, PanIN, and tumor growth, suggesting that LCN2 in the TME is an important determinant for PDAC progression and patient prognosis, similar to MMP-9.